Former Scunthorpe manager supports cancer research trial, championing clinical advances
Angeline Saunderson joins hospital trial, contributing to regional research breakthroughs
A hospital-based research trial has opened doors for Angeline Saunderson, a 63-year-old former local authority manager from Scunthorpe, whose participation is driven by personal loss and a resolve to contribute to cancer research.
Invited to the Queen’s Centre for Oncology and Haematology's trial in November 2024, Angeline embraced the opportunity, motivated by her second diagnosis of triple negative breast cancer (TNBC) and the loss of her sister and father to cancer.
Reflecting on the decision, Angeline stated, "I strongly believe that, without trials, we will never make progress towards eliminating cancer or managing it like a chronic illness, so I was up for doing my bit."
Her candidacy for a cancer trial had played a part in her sister’s plight years earlier, making this chance all the more significant.
Starting the two-year trial in November 2024, Angeline embarked on regular travel to Castle Hill Hospital for chemotherapy and a trial drug.
With fortnightly blood tests accompanying the regimen, Angeline readily committed to the programme, bolstered by the clinicians' dedication.
"I agreed to the trial knowing that it was a commitment for the next two years, but I felt that if the trials team here were willing to invest in me, in stabilising my illness and giving me a good quality of life, then that was a benefit to me, so it was really no bind at all," she explained.
Midway through the trial, Angeline reported positive experiences under expert oncological care.
"I had a few dodgy days near the start, but that’s to be expected, and all along the way I’ve had the support of a really skilled oncologist and close monitoring by the nursing team," she said.
Emphasising the life-extending impact, Angeline observed, "My life has continued as normally as is possible."
Her participation promises broader benefits beyond individual survival, assisting research that aspires to discover new treatments.
“My participation doesn’t just help me, but it will help other patients like me in the future,” Angeline noted.
Her journey aligns with data positioning hospitals across the Humber at the forefront of regional clinical research initiatives.
James Illingworth, Research and Development Manager for NHS Humber Health Partnership, expressed pride in local research strength and reiterated the value of community participation in trials.
“The Hull and Humber region has a fantastic reputation as far as clinical research goes; it’s something we pride ourselves on and our local hospital teams are always looking for opportunities to push the boundaries of research,” Illingworth said.
Across Humber facilities, including Hull Royal Infirmary and Scunthorpe General Hospital, over 15,824 participants engaged in research from April 2025 to March 2026.
James Illingworth conveyed the impact on public health and the role of research in attracting skilled healthcare professionals.
“It’s great to think that people here in East Yorkshire and Northern Lincolnshire could be contributing to life-changing advances in care and treatment,” he added.
The Humber Health Partnership continues steering research across its facilities, pioneering services for millions of patients annually.
Local residents are encouraged to explore participation opportunities, enhancing healthcare outcomes for themselves and future generations.